Ads
related to: License-Agreement and Clinical Development
Search results
Q1 2024 Lineage Cell Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 hours agoTaking the future...week. We announced just a few minutes ago that we have entered into a new services agreement with Genentech, which will provide additional support to the ...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
NBC 17 Raleigh· 17 hours ago...stand-alone adjuvanted COVID-19 vaccine worldwide (except in countries with existing Advance Purchase Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu...
... For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods - Enveric...
Benzinga· 2 days agoEnveric Biosciences ENVB, a Nasdaq-listed psychedelics biotech firm, has entered into a non-binding...
Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between...
Digital Journal· 1 day ago(NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central...together with its affiliate Rgene ...
Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ...
WFRV 5 Green Bay· 2 days agoNEW YORK, May 8, 2024 /PRNewswire/ -- Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today announced entry into an exclusive
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoClearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development
Anixa expands cancer vaccine collaboration with Cleveland Clinic
Pharmaceutical Technology via Yahoo Finance· 2 days agoA vaccine for ovarian cancer, currently in pre-clinical stages, is also being developed by Cleveland...
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302
Digital Journal· 3 days agoAbout...and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly-owned subsidiary, Lucid Psycheceuticals...sclerosis, in preclinical ...
Protagonist Therapeutics to Participate in the Citizens JMP Life Sciences Conference and the Capital...
Digital Journal· 3 days agoRusfertide, a mimetic of the natural hormone hepcidin, is the Company's lead drug candidate currently in a global...vera. Rusfertide is being co-developed and co-commercialized with Takeda pursuant ...
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
Lodi News-Sentinel· 1 day agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today reported ...
